CheckRare

Acromegaly Highlights from ENDO 2021

Overview / Abstract:	This CME activity highlights the latest research about Acromegaly that was presented at ENDO 2021, the annual meeting of the Endocrine Society. This activity provides expert analysis on that research and its clinical relevance for busy members of the care team in order to help them care for patients with acromegaly.
Expiration	Jun 30, 2022
Discipline(s)	Nurse Practitioner , Physician CME, Physician Assistant CME, Radiology / RAD Tech CE
Credits / Hours	0.25
Accreditation	Accreditation Council for Continuing Medical Education (ACCME)
Presenters / Authors / Faculty	Maria Fleseriu, MD, FACE Professor of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Professor of Neurological Surgery, School of Medicine Director of Pituitary Center Oregon Health & Science University Portland, Oregon
Activity Specialities / Related Topics	Critical Care / Intensive Care, Endocrinology, Family Medicine, Infectious Disease, Neurology, Oncology / Cancer / Radiation Therapy, Pulmonary Medicine / COPD, Radiology / Imagery / Nuclear Medicine, Surgery
Sponsors / Supporters / Grant Providers	Ipsen Biopharmaceuticals
Keywords / Search Terms	CheckRare Acromegaly, rare disease, CheckRare, Rare Disorder, Ipsen, Maria Fleseriu MD, ENDO 2021, rare endocrine disorder, enign tumor in the pituitary gland, growth hormone, orphan drug, Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map